Literature DB >> 9554253

Oral contraceptives and risk of venous thromboembolism: impact of duration of use.

T M Farley, O Meirik, M G Marmot, C L Chang, N R Poulter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9554253     DOI： 10.1016/s0010-7824(97)00209-6

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  7 in total

1.  Diane-35 (cyproterone acetate): safety concerns.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2003-02-18       Impact factor: 8.262

Review 2.  Cardiovascular events associated with different combined oral contraceptives: a review of current data.

Authors:  P Hannaford
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

3.  Oral contraceptives, venous thromboembolism, and the courts.

Authors:  David C G Skegg
Journal:  BMJ       Date:  2002-09-07

4.  Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Serge Cremers; Andrew Eisenberger; Stella Thomassen; Jan Rosing
Journal:  Contraception       Date:  2017-01-11       Impact factor: 3.375

5.  Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Authors:  Pansakorn Tanratana; Paul Ellery; Pamela Westmark; Alan E Mast; John P Sheehan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-02       Impact factor: 8.311

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

7.  Clotting factor changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Andrew Eisenberger; Rosalind Tang; Serge Cremers; Lisa V Grossman; Malcolm C Pike
Journal:  Contraception       Date:  2015-10-09       Impact factor: 3.375
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.